Background. Pulmonologists provide quality care, however, their number is not adequate to take care of all the chronic obstructive pulmonary disease (COPD) needs of the population and their services come with a cost. Their optimal role should be defined, ideally based on evidence, to ensure that their abilities are applied most efficiently where needed. Objective. To determine if concomitant pulmonologist and primary care physician care after COPD hospital or emergency department discharge was associated with better health outcomes than primary care services alone. Methods. A population cohort study was conducted in Ontario, Canada from 2004 to 2011. All individuals with a COPD hospital or emergency department discharge were included. Patients who visited both a pulmonologist and a primary care physician within 30 days of the index discharge were matched to patients who had visited a primary care physician alone using propensity scores. The composite outcome of death, COPD hospitalization or COPD emergency department visit was compared using proportional hazards regression. Results. In the propensity score matched sample, 39.7% of patients who received concomitant care and 38.9% who received primary care only died or visited the emergency department visit or hospital for COPD within 1 year (adjusted hazard ratio 1.08, 95% confidence interval 1.00-1.17). The former, however, were more likely to receive diagnostic testing and medications. Conclusion. Patients who received concomitant care after COPD emergency department or hospital discharge did not have better outcomes than those who received primary care alone, however, they did receive more testing and medical management.
Introduction
The prevalence of chronic obstructive pulmonary disease (COPD) is greater than 10% among adults and increasing (1, 2) . Pulmonologists provide valuable COPD care, however, their number is not adequate to care for all the COPD needs of the population and their services come with a cost, albeit usually not an excessive one. The optimal role of COPD specialist physicians should be defined, ideally based on evidence, to ensure their abilities are applied most effectively and efficiently where and when needed.
Currently, most COPD guidelines do not recommend that specialists routinely be involved in COPD care (3) . Studies have suggested that COPD patients receive better or the same care from pulmonologist as primary care physicians, but to the best of our knowledge, none have examined the impact of these physicians working concomitantly (4, 5) . Studies of other chronic diseases have shown that primary and specialist physicians working together in an integrated structure, a process known as collaborative care, can result in better health outcomes, such as decreased hospitalizations, for patients (6) . Often in the real world, however, primary care physicians and pulmonologists neither work in silos, nor have the structure to truly work collaboratively. Thus an intermediate approach is usually taken where patients are seen concomitantly by primary care and specialist physicians who communicate through notes and, sometimes, the patients themselves.
The aim of the current study was to determine if individuals with COPD who received concomitant care by a pulmonologist and primary care physician shortly after COPD emergency department or hospital discharge, had less all-cause mortality, COPDhospitalizations and COPD emergency department visits compared to those who received primary care alone. It also aimed to identify if COPD patients with certain characteristics, such as greater disease severity or comorbidity, had greater benefit from concomitant care than others.
METHODS

Study design and setting
A population-based study of all residents of Ontario, Canada with COPD who were discharged from a COPD emergency department visit or hospitalization between April 1st, 2004 and March 31st, 2010 was conducted. Ontario, the largest province of Canada, has a diverse multicultural population of ~13 million.
Ethics
This study was approved by the ethics review board at Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. For details on data protection and procedures please see www.ices.on.ca.
Data sources
Residents of Ontario have universal public health insurance with a single payer for all medically necessary services across the full spectrum of residents, providers and hospitals. Service details are captured in health administrative databases which can be linked on an individual level to provide complete health services profiles for each resident. The exception is prescription medications, which are provided only to those aged 65 years or older and those on social assistance. The study used the following health administrative databases: the Canadian Institute for Health Information (CIHI) Discharge Abstract Database, contains clinical information, including diagnoses for all hospital admissions in Ontario; the CIHI National Ambulatory Care Report System contains information about emergency department visits; the Ontario Health Insurance Plan Physician Claims database contains information about all physician services, including ambulatory care visits; the Ontario Drug Benefits Database contains information about all prescription medications for people aged 65 and older, and the Registered Persons Database contains basic demographic data and date of death (where applicable). The study used the Institute for Clinical Evaluative Sciences (ICES) physician database to determine physician demographics and specialty-the latter of which is determined from telephone survey. These datasets were linked using unique encoded identifiers and analyzed at ICES. Details on these databases, their validation for health services research and their use in the study of respiratory diseases can be found elsewhere (7) (8) (9) .
Study population
The study cohort included of all individuals with COPD who were discharged from a COPD emergency department visit or hospitalization and who had an ambulatory care visit with a primary care physician in the following 30 days. The discharge date was the index date, and if there were multiple such discharges during the study period, only the first was considered. Individuals with physiciandiagnosed COPD were identified using the Ontario COPD Database, which uses a previously validated COPD case definition of two or more COPD ambulatory care visits and/or one or more COPD hospitalizations in 2 years as per the health administrative databases described above. Codes used to identify COPD were: 491, 492, 496 (Ontario Health Insurance Plan and ICD 9th revision) and J41, J42, J43, J44 (ICD 10th revision), respectively. This case definition had a sensitivity of 65.5% and specificity of 91.5% when compared with clinical evaluation and has been previously used in several other health services research studies (7, 8) .
Patients who experienced an outcome or died within 30 days of the index discharge were excluded. This was because these events were more likely to have been influenced by the index event than the exposure and those who died early would have been more likely to have seen a primary care physician alone, as primary care appointments are usually available sooner than pulmonologist appointments in Ontario. Patients who moved out of the province were also excluded.
Exposure
The primary exposure, concomitant care, was compared to primary care alone. Concomitant care was determined to have occurred if a patient had a pulmonologist ambulatory care visit in addition to a primary care physician, in the 30 days after the index discharge. The amount of interaction between the physicians could not be determined from the data. Primary care alone was defined as an ambulatory care visit with a primary care physician only in the 30 days following the index discharge. In sensitivity analyses exposure periods of two weeks and three months were also examined.
Outcomes
The primary outcome was a composite outcome consisting of allcause mortality, COPD-hospitalizations and COPD emergency department visits in the 1 year following the 30-day exposure period. All-cause mortality was considered because COPD has been found to be underestimated as a cause of death by about 50% in vital statistics records, wherein COPD deaths are often attributed to comorbidities like pneumonia (10) . Secondary outcomes were COPD hospitalizations, COPD emergency department visits and allcause mortality separately and the composite outcome of all-cause mortality, all-cause hospitalizations and all-cause emergency department visits.
Process of care outcomes, including receiving chest X-rays, pulmonary functioning testing (PFT), and commonly used COPD medications within 100 days following the index date, were also 
Potential confounders
A number of demographic, health service utilization, comorbidity, and physician characteristics were derived from the health administrative data (Table 1) . Socioeconomic status was derived ecologically using postal codes to determine the median household incomes of individuals' neighborhoods (11). Rurality was determined using Statistics Canada's definition (12) . Characteristics of patients' primary care physicians were examined because of their observed association with quality of COPD care (12) .
Analysis
Propensity score matching was used to compare patients with similar observed characteristics, all of whom were potential users of concomitant or primary care. Propensity scores, which reflected the probability that patients received concomitant care given their baseline characteristics, were derived using a logistic regression model in which receipt of concomitant care was regressed on potential confounding variables (Table 1 ) (14) . Patients who received concomitant care were matched to individuals who received primary care alone one to one on age (within 1 year), sex, number of hospitalizations in the preceding year, whether the index event was a COPD emergency department visit or a hospital admission, whether they had a pulmonologist visit in the previous year, whether they had received spirometry in the previous five years, and the logit of the propensity score (within 0.2 standard deviations) (15) . Standardized differences were used to examine the distribution of variables, with less than 0.1 accepted as good equilibrium (16). Patients were followed up from 30 days after the index discharge until they had an outcome of interest, died, left the province or reached the end of the 1-year follow-up period (whichever occurred first). In sensitivity analyses 2, 3 and 5-year follow-up periods were examined. The effect of concomitant care on the hazard of the outcome of interest was estimated using Cox proportional hazards regression. Robust variance estimators were used to account for the matched nature of the sample (17) . Individuals who received concomitant care were compared to patients who saw a primary care physician alone. SAS version 9.4 (SAS Institute, Cary, NC) and a two-tailed type 1 error rate of 0.05 as the threshold for statistical significance was used. Patients with missing data were not included in the analyses.
Subgroup analyses
The study examined whether the effect of concomitant care was modified within the following a priori specified subgroups: (i) level of comorbidity (high/low); (ii) absence/presence of a second respiratory disease; (iii) age (≤/> 65 years) (iv) type of index event (hospitalization/emergency department visit) and (v) previous spirometry, to determine if certain individuals derived a greater benefit from concomitant care than others. It also looked for an association with urban/rural residence because individuals living in rural areas may not easily access a pulmonologist. To do so, for each subgroup variable, the main analysis was repeated with the addition of the subgroup variable and the interaction of the primary exposure variable (concomitant care versus primary care alone) and the subgroup variable. A statistically significant interaction term (P < 0.05) was taken to indicate that the effect of concomitant care differed across the levels of the subgroup variable.
Sensitivity analysis
A number of sensitivity analyses to assess the robustness of our findings to different assumptions were conducted. Details can be found in Supplementary Data.
Results
Study population
The study sample consisted of 38 760 patients. Of these, 4981 patients received concomitant care and 33 779 patients received primary care alone within 30 days of a COPD emergency department visit or hospital discharge. Prior to propensity score matching, people who received concomitant care were less likely to live in a long-term care facility, more likely to live in urban areas, and more likely to have co-existing asthma than those who received primary care alone ( Region of the province and index year, not shown here, also included in propensity score. The standardized difference is the mean difference as a percentage of the average standard deviation. 
Primary and secondary outcomes
In the propensity score matched sample, 1816 (39.7%) of patients who received concomitant care and 1,782 (38.9%) who received primary care only had an all-cause death, COPD emergency department visit or COPD hospitalization within 1 year (adjusted hazard ratio 1.08, 95% confidence interval 1.00-1.17) ( Table 2 ; Figure 1 ). Similarly, there were no significant differences in rates of secondary outcomes between the groups ( Table 2 ), except that the rate of COPD hospitalizations was slightly higher in the concomitant group (adjusted hazard ratio 1.12, 95% confidence interval 1.02-1.24).
Processes of care
Individuals who received concomitant care received chest X-rays, pulmonary function testing and, those who were age 65 and older, commonly-used COPD medications at higher rates than those who received primary care alone (all P < 0.001) ( Table 3) .
Subgroup analyses
Separate analyses of subgroups with high and low comorbidity, the presence and absence of a second respiratory disease, aged more or less than 65, living in rural and urban areas, whose index event was a hospitalization or emergency department visit or who did and did not previously receive spirometry found no statistically significant inter-group differences in the composite outcome.
Sensitivity analysis
A number of sensitivity analyses performed to assess the robustness of our findings to different assumptions revealed findings consistent with the primary analyses. Details can be found in Supplementary Data.
Discussion
We conducted a population cohort study of people with COPD and found that concomitant care by a pulmonologist and primary care physician after COPD hospitalization or emergency department discharge was associated with increased receipt of COPD medications and diagnostic tests, but not a decrease in the composite outcome of death, COPD hospitalization or COPD emergency department visit compared to primary care alone. This finding was consistent across patients of varying ages, comorbidity and geographic area. To the best of our knowledge, this is the largest study to evaluate concomitant care in individuals with COPD after hospitalization and emergency department discharge and it does not appear to support its use in this setting. These results can be used to begin to define the optimal role of pulmonologists in COPD care.
Our results are consistent with a previous study showing that hospitalized COPD patients managed by a pulmonologist had no better survival and were just as likely to be readmitted at 30 days as those cared for by a generalist (4) . It also aligns with a study that found increased rates of pharmacological and non-pharmacological treatments, but similar rates of hospital readmission in COPD outpatients managed by a pulmonologist alone compared to a primary care physician alone (5) . Our study expands these findings by examining concomitant and not just pulmonologist care, focussing on exposure in the critical period immediately following an emergency department visit or hospitalization, by taking into account several important potential confounders and by examining subgroups of patients with specific characteristics. Finally, our results are consistent with studies that found no benefit of collaborative care for chronic conditions such as hypertension (6) . Our study was not consistent with a previous study that found concomitant care reduced mortality in older people with COPD; however, this could have been because-unlike the previous study-our study adjusted for overall quality of care and other potential confounders attenuating any positive association seen between concomitant care and the outcomes (18) . We speculate that people who received concomitant care did not have better outcomes because the management options available for people with COPD after an acute event are straightforward and relatively limited. In contrast, diseases that appear to respond to concomitant care, such as heart failure and diabetes, require management-such as diuresis and glycemic control-that is less algorithmic and more experiential (6, 19) . Their suboptimal management might also be more likely to result in an emergency department visit or hospitalization than suboptimal management of COPD. Finally, specialists can sometimes offer unique, definitive treatments, like cardiac catheterization, that change the course of these diseases. Such options are not available for COPD.
By virtue of the fact that they had just been discharged from the hospital or emergency department, the people in our study likely had severe disease and warranted being on all the medications studied. Thus our results suggest that patients receiving concomitant care were more likely to receive practise guideline-based care than those receiving primary care alone (3). Practical barriers in implementation, for example poor inhaler technique and suboptimal medication adherence, might have prevented this from improving health outcomes (20) . Alternatively or additionally, low effectiveness of treatments in the early post discharge period might have played a role. Finally, people who received concomitant care may have had better outcomes that we were unable to measure, such as exercise capacity or quality of life.
Our findings demonstrated that concomitant care similar to that used in many regions is not an improvement over primary physician care after COPD hospital or emergency department discharge. It does not indicate that concomitant care that is employed in other situations-such as at early stages of disease-or with more collaboration, would not help people with COPD. These would be areas deserving further investigation. 
Strengths and limitations
The strengths of our study were its ability to measure the real world experiences of a large, complete population of individuals with COPD and to examine specific subgroups. It also had limitations which merit emphasis. Most concerning is unmeasured confounding, mostly due to disease severity, since we had no measure of lung function. We did know patients' exacerbation rate, however, which has been shown to be a more reliable predictor of COPD hospitalization and mortality than lung function (3). In addition, all patients were recently discharged from a COPD hospitalization or emergency department visit, establishing a similar minimal disease severity. Nonetheless, those with more complicated and severe disease were more likely to have seen a pulmonologist in the past-a variable found to be highly correlated with concomitant care. While our analysis thoroughly adjusted for this variable and other markers of COPD severity, there is a small possibility that that is why we did not find more favorable outcomes in the concomitant care group. A second limitation was diagnostic misclassification that might not have been evenly distributed between patients receiving concomitant and primary care. As patients receiving concomitant care were more likely to have seen a pulmonologist, and pulmonologists are more likely to order pulmonary function testing, those who received concomitant care were more likely to have accurate COPD diagnoses (21) . Thus their outcomes were more likely to be designated as being due to COPD. This might have been the reason for higher in COPD hospitalizations seen in the concomitant care group. This is not likely, however, to affect the all-cause secondary outcomes.
A third limitation was that the amount of interaction between pulmonologists and primary care physicians in the concomitant care group could not be determined from the data. Further research should exam how these physicians communicate and relate to each other and how this can be optimized to benefit patients.
A final limitation was that we only examined the impact of concomitant care after first hospital or emergency department discharge. Further study is needed to examine its impact in patients with repeat COPD admissions-some of the most frequent users of health care.
Conclusion
In conclusion, our population cohort study found that concomitant care by a pulmonologist and primary care physician for individuals with COPD discharged from the hospital or emergency department was not associated with less deaths, COPD hospitalizations or emergency department visits, but was associated with higher rates of guideline based care. These findings do not indicate that concomitant care that is employed in other situations or with consistent collaboration, would not benefit with COPD. Future research should evaluate the benefits of collaborative care and early concomitant care for people with COPD.
Supplementary material
Supplementary data are available at Family Practice online.
